Showing results (581-590 of 631) with videos related to

Sort By:
Pageof 64
Cell Reports|October 3, 2019
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular NeovascularizationPaulina M Wojnarowicz, Raquel Lima E Silva, Masayuki Ohnaka, et al.
Nature Medicine|April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
JACC. Clinical Electrophysiology|April 24, 2025
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory CardiomyopathyGiovanni Peretto, Stefania Rizzo, Andrea Menegon, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
Rheumatology (Oxford, England)|July 28, 2021
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19Martina Orlandi, Nicholas Landini, Gianluca Sambataro, et al.
Seminars in Arthritis and Rheumatism|July 13, 2021
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain setJoanna Tieu, Jonathan Tl Cheah, Rachel J Black, et al.
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Rheumatology (Oxford, England)|August 7, 2021
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsArsène Mekinian, Lucie Biard, Lorenzo Dagna, et al.
Pageof 64